Catheterization and Cardiovascular Interventions · 2010 · 67 citations · 27 references
MedicineCardiologyPediatricsInterventional CardiologyPediatric CardiologyPulmonologyHypertension In ChildrenPediatric Interventional CardiologyPulmonary Artery CatheterizationPulmonary HypertensionIdiopathic Pulmonary HypertensionInhaled Nitric Oxide TherapyPediatric CatheterizationPediatric Pulmonary HypertensionPulmonary Arterial PressurePulmonary Artery Pressure MeasurementPulmonary HemodynamicsPulmonary Hypertension Due To Congenital Heart Disease
OBJECTIVES: To assess protocols, demographics, and hemodynamics in pediatric patients undergoing catheterization for pulmonary hypertension (PH). BACKGROUND: Pediatric specific data is limited on PH. METHODS: Review of the Mid-Atlantic Group of Interventional Cardiology (MAGIC) collaboration PH registry dataset. RESULTS: Between November 2003 and October 2008, seven institutions submitted data from 177 initial catheterizations in pediatric patients with suspected PH. Pulmonary arterial hypertension associated with congenital heart disease (APAH-CHD) (n = 61, 34%) was more common than idiopathic PAH (IPAH) (n = 36, 20%). IPAH patients were older with higher mean pulmonary arterial pressures (mPAP) (P < 0.01). Oxygen lowered mPAP in patients with IPAH (P < 0.01) and associated PAH not related to congenital heart disease (APAH-non CHD) (P < 0.01). A synergistic effect was seen with inhaled nitric oxide (iNO) (P < 0.01). Overall 9/30 (29%) patients with IPAH and 8/48 (16%) patients with APAH-non CHD were reactive to vasodilator testing. Oxygen lowered pulmonary vascular resistance index (PVRI) in patients with APAH-CHD (P < 0.01). There was no additive effect with iNO but a subset of patients required iNO to lower PVRI below 5 WU·m(2). General anesthesia (GA) lowered systemic arterial pressure (P < 0.01) with no difference between GA and procedural sedation on mPAP or PVRI. Adverse events were rare (n = 7) with no procedural deaths. CONCLUSIONS: Pediatric patients with PH demonstrate a higher incidence of APAH-CHD and neonatal specific disorders compared to adults. Pediatric PH patients may demonstrate baseline mPAP < 40 mm Hg but > 50% systemic illustrating the difficulty in applying adult criteria to children with PH. Catheterization in children with PH is relatively safe.
27
Survival in Patients with Primary Pulmonary Hypertension
Gilbert E. D’Alonzo, Robyn J. Barst, Stephen M. Ayres et al. · Annals of Internal Medicine · 1991 · 3.5K citations
Primary Pulmonary Hypertension
Stuart Rich · Annals of Internal Medicine · 1987 · 2.1K citations
Pulmonary Arterial Hypertension in France
Marc Humbert, Olivier Sitbon, Ari Chaouat et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 2K citations